BENEFITING: Abzyme Research Foundation
How it works:
HIV is difficult to vaccinate against because it is constantly mutating, changing faster than the antibodies our bodies produce to fight it.
Dr. Sudhir Paul has invented an E-Vaccine that charges a mostly unchanging part of the virus. This charge allows the immune system to identify and attack this part of the virus, making it vulnerable for the first time. We believe that this approach could both be a preventive vaccine and a potential cure for millions of HIV+ people who do not have access to care.
Our first goal is to test this as a therapeutic.